Prostate Cancer Therapy
Researchers at Erasmus University target prostate cancer therapy
Published in Cancer Weekly, May 22nd, 2007
Scientists discuss in "Early versus delayed endocrine therapy for prostate cancer" new findings in prostate cancer. "Endocrine treatment (ET) has in the past been shown to be beneficial in delaying clinical progression in all stages of prostate cancer, leading to an improvement of progression free survival in virtually all trials ever conducted. The first observations on this issue date back to the studies of the Veterans Administration Cooperative Urological Research Group in the 1960s," scientists in Rotterdam, Netherlands report.
"The period of time during which ET and the resulting side effects can be avoided is strongly dependent on the clinical stage of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-22)
More Articles from Cancer Weekly
- Cancer Vaccines
Animal study identifies promising new target for brain tumor therapy - Cancer Vaccines
HPV infection linked to throat cancers - Cancer Vaccines
National Women’s Health Week Brings Reminder: Take Care of Yourself - Cancer Vaccines
Stanford researchers identify immune dysfunction in melanoma patients - Cancer Vaccines
Study shows continued success for new HPV vaccine against virus responsible for cervical cancer - Colon Cancer
Comparison of patients' access to new and better cancer drugs reveals inequalities between countries - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
